Literature DB >> 4598115

Effects of exogenous estrogen and progestin on pituitary responsiveness to synthetic luteinizing hormone-releasing factor.

G Vandenberg, G DeVane, S S Yen.   

Abstract

The effect of estrogen and progestin on pituitary responsiveness to 150 mug synthetic luteinizing hormone-releasing factor (LRF) was assessed in premenopausal women receiving sequential (n=12) and combination (n=7) contraceptive steroids. A marked contrast in the time-course and maximal response to LRF was found; a prompt but quantitatively smaller luteinizing hormone (LH) response was seen during cyclic combination therapy, while a delayed (five times) but enhanced (fivefold) LH response was observed during estrogen segments of cyclic sequential therapy. For follicle-stimulating hormone (FSH), the maximum rise was also higher, and the peak response was similarly delayed in the latter group. The quantitative secretion in response to LRF for LH (area under the curve), but not for FSH, was significantly greater (P < 0.01) in subjects receiving sequential, as compared to subjects receiving combination treatment. In both groups, characteristic gonadotropin responses to LRF were reproducible and were independent of the duration of treatment. Since LRF studies were performed during the estrogen segment of treatment cycle in subjects receiving sequential steroids, our data suggest that estrogen exerts a direct feedback action at the pituitary level and that pituitary responsiveness to LRF is augmented by estrogen.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4598115      PMCID: PMC302672          DOI: 10.1172/JCI107727

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  9 in total

1.  Augmented gonadotropin response to synthetic LRF in hypogonadal state.

Authors:  T M Siler; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1973-09       Impact factor: 5.958

2.  Variation of pituitary responsiveness to synthetic LRF during different phases of the menstrual cycle.

Authors:  S S Yen; G VandenBerg; R Rebar; Y Ehara
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

3.  Variation in LH and FSH response to LH-releasing hormone during the menstrual cycle.

Authors:  S J Nillius; L Wide
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-10

Review 4.  Clinical experience with hypothalamic releasing hormones. 2. Luteinizing hormone-releasing hormone and other hypophysiotropic releasing hormones.

Authors:  A J Kastin; C Gual; A V Schally
Journal:  Recent Prog Horm Res       Date:  1972

5.  Release of LH and FSH after administration of synthetic LH-releasing hormone.

Authors:  A J Kastin; A V Schally; C Gual; A Arimura
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

6.  Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man.

Authors:  S S Yen; O Llerena; B Little; O H Pearson
Journal:  J Clin Endocrinol Metab       Date:  1968-12       Impact factor: 5.958

7.  Disappearance rates of endogenous follicle-stimulating hormone in serum following surgical hypophysectomy in man.

Authors:  S C Yen; L A Llerena; O H Pearson; A S Littell
Journal:  J Clin Endocrinol Metab       Date:  1970-03       Impact factor: 5.958

8.  Stimulation of LH release in men and women by LH-releasing hormone purified from porcine hypothalami.

Authors:  A J Kastin; A V Schally; C Gual; A R Midgley; C Y Bowers; A Diaz-Infante
Journal:  J Clin Endocrinol Metab       Date:  1969-08       Impact factor: 5.958

9.  Insulin responses to glucose: evidence for a two pool system in man.

Authors:  D Porte; A A Pupo
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

  9 in total
  3 in total

1.  Direct evidence of estrogen modulation of pituitary sensitivity to luteinizing hormone-releasing factor during the menstrual cycle.

Authors:  C F Wang; S S Yen
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

2.  Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.

Authors:  R Rebar; H L Judd; S S Yen; J Rakoff; G Vandenberg; F Naftolin
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

3.  Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.

Authors:  Fernando M Reis; Larissa M Coutinho; Silvia Vannuccini; Frédéric Batteux; Charles Chapron; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.